Adriamycin affects plasma membrane redox functions |
| |
| Authors: | FL Crane WC MacKellar DJ Morre T Ramasarma H Goldenberg C Grebing H Löw |
| |
| Institution: | 1. Dept. of Biological Sciences Purdue University, W. Lafayette, Indiana, USA;2. Dept. of Medicinal Chemistry and Pharmacognosy Purdue University, W. Lafayette, Indiana, USA;3. Dept. of Biochemistry, Indian Institute of Science, Bangalore, India;4. Dept. of Medical Chemistry, University of Vienna, Austria;5. Dept. of Endocrinology and Metabolism, Karolinska Hospital, Stockholm, Sweden |
| |
| Abstract: | Adriamycin (Doxorubicin) stimulates NADH oxidase activity in liver plasma membrane, but does not cause NADH oxidase activity to appear where it is not initially present, as in erythrocyte membrane. NADH dehydrogenase from rat liver and erythrocyte plasma membranes shows similar adriamycin effects with other electron acceptors. Both NADH ferricyanide reductase and vanadate-stimulated NADH oxidation are inhibited by adriamycin, as is a cyanide insensitive ascorbate oxidase activity, whereas NADH cytochrome c reductase is not affected. The effects may contribute to the growth inhibitory (control) and/or deleterious effects of adriamycin. It is clear that adriamycin effects on the plasma membrane dehydrogenase involve more than a simple catalysis of superoxide formation. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
